Fusion Between Transcription Factor CBFβ/PEBP2β and a Myosin Heavy Chain in Acute Myeloid Leukemia
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
The pericentric inversion of chromosome 16 [inv(16)(p13q22)] is a characteristic karyotypic abnormality associated with acute myeloid leukemia, most commonly of the M4Eo subtype. The 16p and 16q breakpoints were pinpointed by yeast artificial chromosome and cosmid cloning, and the two genes involved in this inversion were identified. On 16q the inversion occurred near the end of the coding region for CBFβ, also known as PEBP2β, a subunit of a heterodimeric transcription factor regulating genes expressed in T cells; on 16p a smooth muscle myosin heavy chain (SMMHC) gene (MYH11) was interrupted. In six of six inv(16) patient samples tested, an in-frame fusion messenger RNA was demonstrated that connected the first 165 amino acids of CBFβ with the tail region of SMMHC. The repeated coiled coil of SMMHC may result in dimerization of the CBFβ fusion protein, which in turn would lead to alterations in transcriptional regulation and contribute to leukemic transformation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A fourth alteration, inv (16), is observed in AML of the M4Eo subtype (French-American-British classification) and indirectly targets AML-1B by fusing CBF-, the gene for the heterodimeric DNA binding partner of AML-1B (71), to the smooth muscle myosin heavy chain gene, MYH11 (35,64).”
From The t(8;21) Fusion Product, AML-1–ETO, Associates with C/EBP-α, Inhibits C/EBP-α-Dependent Transcription, and Blocks Granulocytic Differentiation (1998) · cites this paper as [35]
In the citing paper
“Consistent with the hypothesis that the inv(16) product titrates AML-1B through physical interactions (35), CBF-- MYH11 represses AML-1B-dependent activation but has only minimal effects on C/EBP-␣.”
From The t(8;21) Fusion Product, AML-1–ETO, Associates with C/EBP-α, Inhibits C/EBP-α-Dependent Transcription, and Blocks Granulocytic Differentiation (1998) · cites this paper as [35]
Citations
Cites
BENNETT, J. M., CATOVSKY, D., DANIEL, M. T., FLANDRIN, G., GALTON, D. A. G., GRALNICK, H. R., & SULTAN, C. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-103-4-620 · Cited by 2,926
de Thé, H., Chomienne, C., Lanotte, M., Degos, L., & Dejean, A. (1990) · Nature · doi:10.1038/347558a0 · Cited by 1,355
A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences
Martin-Zanca, D., Hughes, S. H., & Barbacid, M. (1986) · Nature · doi:10.1038/319743a0 · Cited by 803
Translocations Among Antibody Genes in Human Cancer
Leder, P., Battey, J., Lenoir, G., Moulding, C., Murphy, W., Potter, H., Stewart, T., & Taub, R. (1983) · Science · doi:10.1126/science.6356357 · Cited by 712
Molecular Analysis of Acute Promyelocytic Leukemia Breakpoint Cluster Region on Chromosome 17
Borrow, J., Goddard, A. D., Sheer, D., & Solomon, E. (1990) · Science · doi:10.1126/science.2218500 · Cited by 632
Ogawa, E., Maruyama, M., Kagoshima, H., Inuzuka, M., Lu, J., Satake, M., Shigesada, K., & Ito, Y. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6859 · Cited by 608
Ogawa, E., Inuzuka, M., Maruyama, M., Satake, M., Naito-Fujimoto, M., Ito, Y., & Shigesada, K. (1993) · Virology · doi:10.1006/viro.1993.1262 · Cited by 493
Le Beau, M. M., Larson, R. A., Bitter, M. A., Vardiman, J. W., Golomb, H. M., & Rowley, J. D. (1983) · New England Journal of Medicine · doi:10.1056/nejm198309153091103 · Cited by 492
Wang, S., Wang, Q., Crute, B. E., Melnikova, I. N., Keller, S. R., & Speck, N. A. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.6.3324-3339.1993 · Cited by 435
Identificaton of a translocation with quinacrine fluorescence in a patient with acute leukemia.
Rowley, J. D. (1973) · PubMed · Cited by 366
Research works printed but not linked: 1
- CALLEN, D.F., Precise localisation of the long arm breakpoint on the inv(16) of ANNL M4Eo and progress towards cloning this breakpoint, AMERICAN JOURNAL OF HUMAN GENETICS 51: A57 (1992).
Cited by
Items 401–500 of 778
Inv(16) acute myeloid leukemia cells show an increased sensitivity to cytosine arabinoside in vitro
Tosi, P., Visani, G., Ottaviani, E., Testoni, N., Pellacani, A., & Tura, S. (1998) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1998.tb01017.x · Cited by 26
Molecular cytogenetics of childhood acute myelogenous leukaemias
Leblanc, T. M., & Berger, R. (1997) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1997.tb00953.x · Cited by 26
Structural and functional characterization of Runx1, CBFβ, and CBFβ-SMMHC
Zhang, L., Lukasik, S. M., Speck, N. A., & Bushweller, J. H. (2003) · Blood Cells Molecules and Diseases · doi:10.1016/s1079-9796(03)00022-6 · Cited by 25
Core Binding Factor Leukemia: Chromatin Remodeling Moves Towards Oncogenic Transcription
Beghini, A. (2019) · Cancers · doi:10.3390/cancers11121973 · Cited by 25
Emerging therapies for inv(16) AML
Surapally, S., Tenen, D. G., & Pulikkan, J. A. (2021) · Blood · doi:10.1182/blood.2020009933 · Cited by 25
Coco, F. L., & Foà, R. (1995) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1995.tb00225.x · Cited by 25
Wierenga, P. K., Setroikromo, R., Kamps, G., Kampinga, H. H., & Vellenga, E. (2003) · Experimental Hematology · doi:10.1016/s0301-472x(03)00049-3 · Cited by 25
Huang, X., Crute, B. E., Sun, C. C., Tang, Y.-Y., Kelley, J. J., Lewis, A. F., Hartman, K. L., Laue, T. M., Speck, N. A., & Bushweller, J. H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.4.2480 · Cited by 25
Viswanatha, D. S., Chen, I.-M., Liu, P. P., Slovak, M. L., Rankin, C., Head, D. R., & Willman, C. L. (1998) · Blood · doi:10.1182/blood.v91.6.1882 · Cited by 25
Self-citationModelling acute myeloid leukaemia in a continuum of differentiation states
Cho, H., Ayers, K., de Pills, L., Kuo, Y., Park, J., Radunskaya, A., & Rockne, R. C. (2018) · Letters in Biomathematics · doi:10.1080/23737867.2018.1472532 · Cited by 24
Metzeler, K. H., & Bloomfield, C. D. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-3233-2_12 · Cited by 24
CBFB-MYH11 hinders early T-cell development and induces massive cell death in the thymus
Zhao, L., Cannons, J. L., Anderson, S. M., Kirby, M., Xu, L., Castilla, L. H., Schwartzberg, P. L., Bosselut, R., & Liu, P. P. (2006) · Blood · doi:10.1182/blood-2006-10-051508 · Cited by 24
Self-citationCommon gene expression signatures in t(8;21)‐ and inv(16)‐acute myeloid leukaemia
Ichikawa, H., Tanabe, K., Mizushima, H., Hayashi, Y., Mizutani, S., Ishii, E., Hongo, T., Kikuchi, A., & Satake, M. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06310.x · Cited by 24
Miano, J. M., Krahe, R., Garcia, E., Elliott, J. M., & Olson, E. N. (1997) · Gene · doi:10.1016/s0378-1119(97)00265-5 · Cited by 24
Wang, C. Q., Chin, D. W. L., Chooi, J.-Y., Chng, W. J., Taniuchi, I., Tergaonkar, V., & Osato, M. (2014) · Leukemia · doi:10.1038/leu.2014.316 · Cited by 23
Panagopoulos, I., Torkildsen, S., Gorunova, L., Tierens, A. M., Tjønnfjord, G. E., & Heim, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096570 · Cited by 23
Hyde, R. K., & Liu, P. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22596 · Cited by 23
Self-citationcDNA cloning of Runx family genes from the pufferfish (Fugu rubripes)
Ng, C. E. L., Osato, M., Tay, B. H., Venkatesh, B., & Ito, Y. (2007) · Gene · doi:10.1016/j.gene.2007.05.014 · Cited by 23
The inv(16) Cooperates with ARF Haploinsufficiency to Induce Acute Myeloid Leukemia
Moreno–Miralles, I., Pan, L., Keates‐Baleeiro, J., Goodwin, K. D., Yang, C., Kim, H., Thompson, M. A., Klug, C. A., Cleveland, J. L., & Hiebert, S. W. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506855200 · Cited by 23
Taylor, D. S., Laubach, J. P., Nathan, D. G., & Mathey-Prévôt, B. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.24.14020 · Cited by 23
RUNX Proteins in Development and Cancer
van Wijnen, A. J., Speck, N. A., Neil, J. C., Liu, P., Ito, Y., & Groner, Y. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-3233-2 · Cited by 23
Self-citationThys, R. G., Lehman, C. E., Pierce, L., & Wang, Y. (2015) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2015.06.011 · Cited by 23
Dysplasia and High Proliferation Rate Are Common in Acute Myeloid Leukemia With inv(16)(p13q22)
Di Lu, M., Rassidakis, G. Z., Carlos Bueso-Ramos, M., Medeiros, M. L. J., & Sun, X. (2003) · American Journal of Clinical Pathology · doi:10.1309/pgnt8lgn9ar4qvaj · Cited by 23
Genomic Assessment of Pediatric Acute Leukemia
Mullighan, C. G., Flotho, C., & Downing, J. R. (2005) · The Cancer Journal · doi:10.1097/00130404-200507000-00003 · Cited by 23
The Clinical Applications of New DNA Diagnostic Technology on the Management of Cancer Patients
Rowley, J. D., Aster, J. C., & Sklar, J. (1993) · JAMA · doi:10.1001/jama.1993.03510190087032 · Cited by 23
Ethelberg, S., Lovmand, J., Schmidt, J., Luz, A., & Pedersen, F. S. (1997) · Journal of Virology · doi:10.1128/jvi.71.10.7273-7280.1997 · Cited by 23
Acute myeloid leukaemia (FAB AML-M4Eo) with cryptic insertion ofcbfbresulting incbfb-Myh11fusion
Douet‐Guilbert, N., Chauveau, A., Guéganic, N., Guillerm, G., Tous, C., Bris, M. L., Basinko, A., Morel, F., Ugo, V., & Braekeleer, M. D. (2015) · Hematological Oncology · doi:10.1002/hon.2268 · Cited by 22
A new angle on a pervasive oncogene
Cleary, M. L. (1999) · Nature Genetics · doi:10.1038/13761 · Cited by 22
Tsuruta, T., Tani, K., Hoshika, A., & Asano, S. (1999) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199909167386 · Cited by 22
Cytogenetic analysis of hematologic malignant diseases
Heerema, N. A. (2017) · Wiley eBooks · doi:10.1002/9781119061199.ch11 · Cited by 22
Transcriptional Regulation by the t(8;21 )Fusion Protein, AML-1/ETO
Hiebert, S. W., Downing, J. R., Lenny, N. T., & Meyers, S. (1996) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-85232-9_25 · Cited by 22
Kuss, B. J., O’Neill, G. M., Eyre, H. J., Doggett, N. A., Callen, D. F., & Davey, R. A. (1998) · Genomics · doi:10.1006/geno.1998.5349 · Cited by 22
Molecular diagnosis and monitoring of acute myeloid leukemia
Biondi, A., & Rambaldi, A. (1996) · Leukemia Research · doi:10.1016/s0145-2126(96)00022-7 · Cited by 22
Morita, K., Maeda, S., Suzuki, K., Kiyose, H., Taniguchi, J., Liu, P. P., Sugiyama, H., Adachi, S., & Kamikubo, Y. (2017) · Blood Advances · doi:10.1182/bloodadvances.2017007591 · Cited by 21
Self-citationKanto, S., Chiba, N., Tanaka, Y., Fujita, S., Endo, M., Kamada, N., Yoshikawa, K., Fukuzaki, A., Orikasa, S., Watanabe, T., et al. (2000) · Leukemia · doi:10.1038/sj.leu.2401821 · Cited by 21
Saida, S., Zhen, T., Kim, E., Yu, K., Lopez, G., McReynolds, L. J., & Liu, P. (2019) · Leukemia · doi:10.1038/s41375-019-0605-7 · Cited by 20
Self-citationSun, X., Zhang, W., Ramdas, L., Stivers, D. N., Jones, D. M., Kantarjian, H. M., Estey, E. H., Vadhan‐Raj, S., Medeiros, L. J., & Bueso-Ramos, C. (2007) · Modern Pathology · doi:10.1038/modpathol.3800829 · Cited by 20
Adelstein, R. S., & Sellers, J. R. (1996) · Elsevier eBooks · doi:10.1016/b978-012078160-7/50004-4 · Cited by 20
Development of the Vertebrate Hematopoietic System
Speck, N. A., Peeters, M. C. E., & Dzierzak, E. A. (2002) · Elsevier eBooks · doi:10.1016/b978-012597951-1/50013-5 · Cited by 20
3′ CBFβ deletion associated with inv(16) in acute myeloid leukemia
Kelly, J., Foot, N. J., Conneally, E., Enright, H., Humphreys, M. W., Saunders, K., & Neat, M. J. (2005) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2005.03.001 · Cited by 20
CBFB/MYH11 fusion in a patient with AML-M4Eo and cytogenetically normal chromosomes 16
Pirc‐Danoewinata, H., Dauwerse, H. G., König, M., Chudoba, I., Mitterbauer, M., Jaeger, U., Breuning, M. H., & Haas, O. A. (2000) · Genes Chromosomes and Cancer · doi:10.1002/1098-2264(2000)9999:9999<::aid-gcc1020>3.0.co;2-0 · Cited by 20
Tallman, M. S. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/1-4020-7920-6_3 · Cited by 20
AML1 haploinsufficiency, gene dosage, and the predisposition to acute leukemia
Barton, K., & Nucifora, G. (2000) · BioEssays · doi:10.1002/(sici)1521-1878(200003)22:3<214::aid-bies2>3.0.co;2-i · Cited by 20
Molecular Characteristics of DNA-Alkylating PI Polyamides Targeting RUNX Transcription Factors
Maeda, R., Sato, S., Obata, S., Ohno, T., Hashiya, K., Bando, T., & Sugiyama, H. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.8b08813 · Cited by 19
CBFB-MYH11 Fusion Sequesters RUNX1 in Cytoplasm to Prevent DNMT3A Recruitment to Target Genes in AML
Liu, P., Liu, J.-P., Sun, S.-J., Gao, Y., Ai, Y., Chen, X., Sun, Y., Zhou, M., Liu, Y., Xiong, Y., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.675424 · Cited by 19
Self-citationNagel, S., Pommerenke, C., Meyer, C., & MacLeod, R. A. F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063192 · Cited by 19
Richter, L. E., Wang, Y., Becker, M. E., Coburn, R. A., Williams, J. T., Amador, C. C., & Hyde, R. K. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0922 · Cited by 19
Pulikkan, J. A., Hegde, M. B., Ahmad, H. M., Belaghzal, H., Illendula, A., Yu, J. Q., O’Hagan, K., Ou, J., Müller‐Tidow, C., Wolfe, S. A., et al. (2018) · Cell · doi:10.1016/j.cell.2018.08.014 · Cited by 19
Role of Nuclear Receptor Corepressors in Leukemogenesis
Guidez, F., & Zelent, A. (2001) · Current topics in microbiology and immunology · doi:10.1007/978-3-662-10595-5_9 · Cited by 19
1 Molecular and cytogenetic abnormalities in acute myeloid leukaemia and myelodysplastic syndromes
de Greef, G. E., & Hagemeijer, A. (1996) · Baillière s Clinical Haematology · doi:10.1016/s0950-3536(96)80034-5 · Cited by 19
Detection of minimal residual disease by polymerase chain reaction in b cell malignancies
Moos, M., Schulz, R., Cremer, F. W., Sucker, C., Schmohl, D., Döhner, H., Goldschmidt, H., Haas, R., & HUNSTEIN, W. (1995) · Stem Cells · doi:10.1002/stem.5530130708 · Cited by 19
Day, R. B., Hickman, J. A., Xu, Z., Katerndahl, C. D. S., Ferraro, F., Ramakrishnan, S. M., Erdmann-Gilmore, P., Sprung, R. W., Mi, Y., Townsend, R. R., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci176311 · Cited by 18
Preleukemia and Leukemia-Initiating Cell Activity in inv(16) Acute Myeloid Leukemia
Pulikkan, J. A., & Castilla, L. H. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00129 · Cited by 18
What Influences the Decision to Proceed to Transplant for Patients With AML in First Remission?
DeWolf, S., Tallman, M. S., Rowe, J. M., & Salman, M. Y. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.22.02868 · Cited by 18
Demoulin, J., & Havelange, V. (2013) · Journal of Blood Medicine · doi:10.2147/jbm.s33142 · Cited by 18
Monitoring AML1-ETO and CBFΒ-MYH11 transcripts in acute myeloid leukemia
Yin, J. A. L., & Frost, L. (2003) · Current Oncology Reports · doi:10.1007/s11912-003-0026-6 · Cited by 18
Döhner, H., Stilgenbauer, S., Fischer, K., der, M. S. O., Bentz, M., & Lichter, P. (1995) · Stem Cells · doi:10.1002/stem.5530130712 · Cited by 18
Kim, J. H., Lee, S., Rho, J. K., & Choe, S. Y. (1999) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(99)00048-5 · Cited by 18
Monma, F., Nishii, K., Shiga, J., Sugahara, H., Lorenzo, F., V, Watanabe, Y., Kawakami, K., Hosokai, N., Yamamori, S., Katayama, N., et al. (2006) · Leukemia Research · doi:10.1016/j.leukres.2006.08.009 · Cited by 18
Diagnosis of Childhood Acute Myeloid Leukemia
Behm, F. G. (1999) · Clinics in Laboratory Medicine · doi:10.1016/s0272-2712(18)30135-5 · Cited by 18
THE CLINICAL VALUE OF DETECTING GENE REARRANGEMENT IN ACUTE LEUKAMIAS:
Shiach, C. R., Potter, M. N., & Morgan, G. J. (1994) · British Journal of Haematology · doi:10.1111/j.1365-2141.1994.tb05060.x · Cited by 18
Laczika, K. F., Mitterbauer, G., Mitterbauer, M., Knöbl, P., Schwarzinger, I., Greinix, H., Rabitsch, W., Fonatsch, C., Mannhalter, C., Lechner, K., et al. (2001) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190109097711 · Cited by 18
The biological significance of the multidrug resistance gene MRP in inversion 16 leukemias
Kuss, B. J., Deeley, R. G., Cole, S. P. C., Willman, C. L., Kopecky, K. J., Wolman, S. R., Eyre, H. J., & Callen, D. F. (1996) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199609052416 · Cited by 18
Mapping of HLA class I binding motifs in forty-four fusion proteins involved in human cancers.
Gambacorti-Passerini, C. B., Bertazzoli, C., Dermime, S., Scardino, A., Schendel, D. J., & Parmiani, G. (1997) · PubMed · Cited by 18
Lanfrancone, L., Pelicci, G., & Pelicci, P. G. (1994) · Current Opinion in Genetics & Development · doi:10.1016/0959-437x(94)90099-x · Cited by 18
Sive, J. I., Basilico, S., Hannah, R., Kinston, S. J., Calero-Nieto, F. J., & Göttgens, B. (2016) · Leukemia · doi:10.1038/leu.2015.172 · Cited by 17
Kamikubo, Y., Hyde, R. K., Zhao, L., Alemu, L., Rivas, C., Garrett, L. J., & Liu, P. P. (2012) · Blood · doi:10.1182/blood-2012-06-434688 · Cited by 17
Self-citationCBFβ-SMMHC slows proliferation of primary murine and human myeloid progenitors
D’Costa, J., Chaudhuri, S., Civin, C. I., & Friedman, A. D. (2005) · Leukemia · doi:10.1038/sj.leu.2403755 · Cited by 17
Kundu, M., & Liu, P. P. (2003) · Blood Cells Molecules and Diseases · doi:10.1016/s1079-9796(03)00030-5 · Cited by 17
Self-citationContribution of immunophenotypic and genotypic analyses to the diagnosis of acute leukemia
Stasi, R., Taylor, C. G., Venditti, A., Poeta, G. D., Aronica, G., Bastianelli, C., Simone, M. D., Buccisano, F., Cox, M. C., Bruno, A., et al. (1995) · Annals of Hematology · doi:10.1007/bf01696228 · Cited by 17
Grardel, N., Roumier, C., Soenen, V., Laï, J., Plantier, I., Gheveart, C., Cosson, A., Fenaux, P., & Preudhomme, C. (2002) · Leukemia · doi:10.1038/sj.leu.2402332 · Cited by 17
Johansson, B., & Harrison, C. J. (2010) · Wiley eBooks · doi:10.1002/9781118010136.ch5 · Cited by 16
The labyrinth of interactions of Epstein-Barr virus-encoded small RNAs
Ahmed, W., & Khan, G. (2013) · Reviews in Medical Virology · doi:10.1002/rmv.1763 · Cited by 16
Characteristics of translocation (16;16)(p13;q22) acute myeloid leukemia
Eghtedar, A., Borthakur, G. M., Ravandi, F., Jabbour, E. J., Cortes, J. E., Pierce, S. A., Kantarjian, H. M., & Garcia‐Manero, G. (2011) · American Journal of Hematology · doi:10.1002/ajh.22258 · Cited by 16
Inversion‐associated translocations in acute myelomonocytic leukemia with eosinophilia
Berger, R., Derré, J., Coniat, M. L., Hebert, J., Romana, P., & Jonveaux, P. (1995) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870120110 · Cited by 16
Krauter, J., Ganser, A., Bergmann, L., Raghavachar, A., Hoelzer, D. T., Lübbert, M., Schlimok, G., Arnold, R., Kirchner, H., Port, M., et al. (1999) · Annals of Hematology · doi:10.1007/s002770050512 · Cited by 16
López‐Camacho, C., van Wijnen, A. J., Lian, J. B., Stein, J. L., & Stein, G. S. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24892 · Cited by 15
Homing of cytokine-induced killer cells during the treatment of acute promyelocytic leukemia
Wang, H., Cao, F., Li, J., Li, Y., Liu, X., Wang, L., Liu, Z., Li, Y., Zhao, H., & Zhou, J. (2014) · International Journal of Hematology · doi:10.1007/s12185-014-1618-7 · Cited by 15
Measurable residual disease testing for personalized treatment of acute myeloid leukemia
Ehinger, M., & Pettersson, L. (2019) · Apmis · doi:10.1111/apm.12926 · Cited by 15
Classification of Acute Leukemias: Perspective 1
Ludwig, W.-D., Haferlach, T., & Schoch, C. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-307-1_1 · Cited by 15
Myint, H., Ross, F. M., Hall, J. L., & Hamblin, T. J. (1997) · Leukemia Research · doi:10.1016/s0145-2126(97)00070-2 · Cited by 15
Molecular genetic diagnosis of pediatric cancer: current and emerging methods
Rowland, J. M. (2002) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(02)00103-7 · Cited by 15
Functional Characterization of TEL/AML1 Fusion Protein in the Regulation of Human CR1 Gene Promoter
Song, H., Kim, J. H., Rho, J. K., Park, S. Y., Kim, C. G., & Choe, S. Y. (1999) · Molecules and Cells · doi:10.1016/s1016-8478(23)13585-0 · Cited by 15
Molecular Diagnosis in Pediatric Acute Leukemias
Bartolo, C., & Viswanatha, D. S. (2000) · Clinics in Laboratory Medicine · doi:10.1016/s0272-2712(18)30081-7 · Cited by 15
Fluorescence In Situ Hybridization Method for Measuring Transfection Efficiency
Cheng, L., Bucana, C. D., & Wei, Q. (1996) · BioTechniques · doi:10.2144/96213rr01 · Cited by 15
Molecular diagnosis of lymphomas and associated diseases
McCarthy, K. (1997) · Cancer and Metastasis Reviews · doi:10.1023/a:1005748424124 · Cited by 15
Proleukemic RUNX1 and CBFβ Mutations in the Pathogenesis of Acute Leukemia
Engel, M. E., & Hiebert, S. W. (2009) · Cancer treatment and research · doi:10.1007/978-0-387-69259-3_8 · Cited by 14
Gene expression profiling for the diagnosis and prognosis of acute myeloid leukaemia
Mills, K. (2008) · Frontiers in bioscience · doi:10.2741/3026 · Cited by 14
Cbfβ Reduces Cbfβ-SMMHC–Associated Acute Myeloid Leukemia in Mice
Heilman, S. A., Kuo, Y., Goudswaard, C. S., Valk, P. J. M., & Castilla, L. H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0959 · Cited by 14
Cho, H., Kuo, Y., & Rockne, R. C. (2022) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2022395 · Cited by 13
CBFβ-SMMHC Affects Genome-wide Polycomb Repressive Complex 1 Activity in Acute Myeloid Leukemia
Cordonnier, G., Mandoli, A., Cagnard, N., Hypolite, G., Lhermitte, L., Verhoeyen, E., Asnafi, V., Dillon, N., Macintyre, E. A., Martens, J. H. A., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2019.12.026 · Cited by 13
Dynamic patterns of microRNA expression during acute myeloid leukemia state-transition
Frankhouser, D. E., O’Meally, D., Branciamore, S., Uechi, L., Zhang, L., Chen, Y., Li, M., Qin, H., Wu, X., Carlesso, N., et al. (2022) · Science Advances · doi:10.1126/sciadv.abj1664 · Cited by 13
RUNX1 and CBFβ Mutations and Activities of Their Wild-Type Alleles in AML
Hyde, R. K., Liu, P., & Friedman, A. D. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-3233-2_17 · Cited by 13
Self-citationG ENETIC P ROFILE OF A CUTE M YELOID L EUKEMIA
Mecucci, C., Rosati, R., & Starza, R. L. (2002) · Reviews in Clinical and Experimental Hematology · doi:10.1046/j.1468-0734.2002.00060.x · Cited by 13
Lymphoid blastic crisis of chronic myelogenous leukaemia with inv(16)(p13;q22)
Tsuboi, K., Komatsu, H., Miwa, H., Iida, S., Banno, S., Wakita, A., Nitta, M., & Ueda, R. (2002) · Leukemia Research · doi:10.1016/s0145-2126(01)00199-0 · Cited by 13
Molecular abnormalities in myeloid leukemias and myelodysplastic syndromes
Sawyers, C. L. (1998) · Leukemia Research · doi:10.1016/s0145-2126(98)00109-x · Cited by 13
Polymerase Chain Reaction in the Diagnosis of Chromosomal Breakpoints
Crisan, D., Chen, S., & Weil, S. C. (1994) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(18)30156-4 · Cited by 13
Yi, G., Mandoli, A., Jussen, L., Tijchon, E. J. H., van Bergen, M. G. J. M., Cordonnier, G., Hansen, M., Kim, B., Nguyen, L. N. M., Jansen, P. W. T. C., et al. (2019) · Blood Cancer Journal · doi:10.1038/s41408-019-0194-8 · Cited by 12
Maly, I. V., & Hofmann, W. A. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-38062-5_10 · Cited by 12
Mitochondria and Their Relationship with Common Genetic Abnormalities in Hematologic Malignancies
Czegle, I., Gray, A. L., Wang, M., Liu, Y., Wang, J., & Wappler-Guzzetta, E. A. (2021) · Life · doi:10.3390/life11121351 · Cited by 12
Metadata
- Authors
- Liu, P., Tarlé, S. A., Hajra, A., Claxton, D. F., Marlton, P., Freedman, M., Siciliano, M. J., & Collins, F. S.
- Affiliations
- Howard Hughes Medical Institute (US)
- The University of Texas MD Anderson Cancer Center (US)
- Venue
- Science
- Published
- 1993-08-20
- Volume
- 261
- Issue
- 5124
- Pages
- 1041-1044
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2047591593
- Cited by
- 732
- References
- 37
- Citations by year
- 2026: 8 · 2025: 7 · 2024: 7 · 2023: 9 · 2022: 11 · 2021: 12 · 2020: 15 · 2019: 13 · 2018: 8 · 2017: 24 · 2016: 8 · 2015: 23 · 2014: 18 · 2013: 14 · 2012: 15
- FWCI
- 25.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA-55164, P01CA055164)
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Keywords
- acute myeloid leukemia, inv(16)(p13q22), CBFβ, smooth muscle myosin heavy chain, MYH11, gene fusion, transcription factors, coiled-coil dimerization, leukemic transformation, karyotype abnormalities
- MeSH terms
- Amino Acid Sequence, Base Sequence, Chromosomes, Human, Pair 16, Cloning, Molecular, Cosmids, DNA-Binding Proteins, Humans, Chromosome Inversion, Molecular Sequence Data, Muscle, Smooth, Myosins, Neoplasm Proteins, Transcription Factors, Restriction Mapping, Leukemia, Myelomonocytic, Acute, Polymerase Chain Reaction, In Situ Hybridization, Fluorescence, Transcription Factor AP-2, Core Binding Factor beta Subunit, Core Binding Factor Alpha 1 Subunit, Core Binding Factors, Protein Multimerization
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.